See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $403B | 6.9x | 15.3x | |
| $391B | 4.6x | 16.8x | |
| $234B | 4.5x | 18.9x | |
| $176B | 2.5x | 11.9x | |
| $77.9B | 3.9x | 15.7x | |
| $70.0B | 1.3x | 6.1x | |
| $67.8B | 9.1x | 39.6x | |
| $57.0B | 3.0x | 10.5x | |
| $54.8B | 3.6x | 14.4x | |
| $49.7B | 3.2x | 13.7x | |
| $48.8B | 5.2x | 21.2x | |
| $39.3B | 7.9x | 34.5x | |
| $37.9B | 2.6x | 19.5x | |
| $33.3B | 1.3x | 7.4x | |
| $25.5B | 2.2x | 12.4x | |
| $25.0B | 4.1x | 17.8x | |
| $23.5B | 2.1x | 13.4x | |
| $23.0B | 2.3x | 6.6x | |
| $21.1B | 1.8x | 12.5x | |
| $20.8B | 1.4x | 7.6x | |
| $15.3B | 8.9x | 41.8x | |
| $13.5B | 8.9x | 35.0x | |
| $12.2B | 2.1x | 14.8x | |
| $11.7B | 2.0x | 10.1x | |
| $10.9B | 8.3x | 42.0x | |
| $10.8B | 7.2x | 38.6x | |
| $10.0B | 1.4x | 7.8x | |
| $8.4B | 1.2x | 11.8x | |
| $8.3B | 1.4x | 7.6x | |
| $7.6B | 10.5x | 32.3x | |
| $7.0B | 8.0x | 19.2x | |
| $7.0B | 1.6x | 9.1x | |
| $6.6B | 2.4x | 10.5x | |
| $6.5B | 4.6x | 21.3x | |
| $6.0B | 13.3x | 42.0x | |
| $5.9B | 1.9x | 13.8x | |
| $5.0B | 9.9x | 41.5x | |
| $4.9B | 6.8x | 32.0x | |
| $4.6B | 4.1x | 12.3x | |
| $4.6B | n/a | n/a | |
| $4.2B | 2.8x | 14.1x | |
| $4.2B | 12.8x | 51.7x | |
| $4.2B | 1.2x | 7.1x | |
| $4.0B | 2.4x | 13.0x | |
| $3.8B | 3.6x | 24.4x | |
| $3.8B | 1.8x | 11.5x | |
| $3.8B | 5.2x | 24.5x | |
| $3.5B | 0.6x | 6.1x | |
| $3.3B | 3.1x | 14.0x | |
| $3.2B | 1.0x | 6.1x | |
| $3.1B | 0.6x | 5.9x | |
| $3.1B | 1.4x | 8.4x | |
| $2.9B | 6.4x | 23.7x | |
| $2.6B | 0.8x | 5.2x | |
| $2.6B | 2.2x | -413.9x | |
| $2.6B | 1.3x | 10.6x | |
| $2.5B | 1.5x | 12.2x | |
| $2.5B | 1.1x | 7.4x | |
| $2.5B | 1.0x | 4.8x | |
| $2.3B | 3.5x | 17.0x | |
| $2.3B | 0.8x | 6.7x | |
| $2.3B | 1.1x | 8.9x | |
| $2.2B | 2.6x | 17.2x | |
| $2.1B | 5.3x | 15.0x | |
| $2.0B | 3.4x | 19.7x | |
| $1.7B | 1.3x | 11.1x | |
| $1.6B | 2.6x | 10.9x | |
| $1.6B | 0.7x | 7.7x | |
| $1.5B | 1.2x | 8.5x | |
| $1.4B | 0.8x | 5.4x | |
| $1.4B | 4.8x | 10.8x | |
| $1.4B | 0.6x | 5.4x | |
| $1.2B | 1.7x | 6.7x | |
| $1.1B | 7.9x | 27.8x | |
| $1.1B | 0.3x | 2.5x | |
| $1.1B | 4.2x | 95.3x | |
| $1.1B | 1.5x | 10.3x | |
| $981M | 2.3x | 9.1x | |
| $768M | n/a | n/a | |
| $704M | n/a | n/a | |
| $665M | 2.1x | -128.7x | |
| $648M | 1.4x | 6.8x | |
| $618M | 0.5x | 5.7x | |
| $615M | 0.8x | 4.5x | |
| $591M | 1.5x | 9.8x | |
| $580M | 0.8x | 6.0x | |
| $496M | 0.3x | n/a | |
| $495M | 2.0x | 20.4x | |
| $464M | 3.0x | 11.8x | |
| $460M | 1.6x | 10.5x | |
| $453M | n/a | n/a | |
| $434M | 1.1x | 15.8x | |
| $415M | n/a | n/a | |
| $404M | 1.3x | 24.3x | |
| $371M | 1.9x | -25.8x | |
| $358M | 1.4x | n/a | |
| $346M | n/a | n/a | |
| $337M | 0.8x | 10.0x | |
| $273M | n/a | n/a | |
| $264M | 1.3x | 8.0x | |
| $260M | 5.3x | 19.8x | |
| $210M | 0.4x | 9.2x | |
| $196M | n/a | n/a | |
| $191M | 1.0x | 10.5x | |
| $167M | n/a | n/a | |
| $138M | 2.3x | 7.5x | |
| $134M | 0.5x | 6.0x | |
| $131M | 2.0x | 9.1x | |
| $102M | n/a | n/a | |
| $98.8M | 0.4x | 5.2x | |
| $59.9M | 1.2x | 9.0x | |
| $57.2M | 2.1x | 8.9x | |
| $44.6M | n/a | n/a | |
| $43.3M | n/a | n/a | |
| $33.2M | n/a | n/a | |
| $26.4M | n/a | n/a | |
| $20.9M | 0.8x | -30.5x | |
| $20.9M | 1.6x | n/a | |
| $19.4M | n/a | n/a | |
| $14.5M | n/a | n/a | |
| $12.3M | n/a | n/a | |
| $11.7M | n/a | n/a | |
| $6.7M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| $0.8M | n/a | n/a | |
| -$2.3M | -0.0x | -0.1x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty